Cargando…
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
BACKGROUND: In vivo studies demonstrate that curcumin increases radioresponse of colorectal cancers. To demonstrate efficacy in humans, we performed a randomized double-blind study of locally advanced rectal cancer (LARC) patients receiving pre-operative chemoradiation therapy (CRT) ± curcumin. We u...
Autores principales: | Gunther, Jillian R., Chadha, Awalpreet S., Guha, Sushovan, Raju, Gottumukkala S., Maru, Dipen M., Munsell, Mark F., Jiang, Yan, Yang, Peiying, Felix, Edd, Clemons, Marilyn, Mathew, Geena George, Singh, Pankaj K., Skibber, John M., Rodriguez-Bigas, Miguel A., Chang, George J., Eng, Cathy, Delclos, Marc E., Crane, Christopher H., Das, Prajnan, Krishnan, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830363/ https://www.ncbi.nlm.nih.gov/pubmed/36636059 http://dx.doi.org/10.21037/jgo-22-259 |
Ejemplares similares
-
Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis
por: Gunther, Jillian R., et al.
Publicado: (2017) -
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer
por: Chadha, Awalpreet S., et al.
Publicado: (2016) -
Metformin use and improved response to therapy in rectal cancer
por: Skinner, Heath D., et al.
Publicado: (2013) -
Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022) -
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)